ImmunityBio Stock Soaring Today: Key Catalysts Unpacked
ImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
Look for warning indicators such as overspending, debt drift, and shrinking savings, then apply targeted corrections to stabilize finances.
16,621 articlesImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
A government study in Ireland finds entry-level tech finance workers face rising AI exposure, with young workers in h...
A single quarterly filing can rewrite a fund’s star players. Tepper’s Appaloosa appears to have shifted away from NVI...
Saluda Grade taps Patrick Lo to join co-CIO leadership and broaden its asset-based finance platform. The move positio...
A wave of catalysts and improving charts push XRP, Bitcoin and Ethereum higher, with traders eyeing potential fresh h...
Investors are weighing Microsoft’s next steps in a fast-changing tech landscape. This guide breaks down likely cataly...
A director sold about $128,000 of Cognex shares, prompting questions about the stock's outlook. This guide breaks dow...
Gary Keller argues that a data-driven view can outweigh market gloom, foreseeing 4.3 million home sales in 2026 and a...
XRP slipped about 4% over the weekend as broader crypto momentum cooled. This article breaks down why it happened, wh...
A veteran Wall Street voice argues that safety plus reliable income now drive retiree portfolios, spotlighting five h...
Vitalik selling ethereum grabs attention in a thin market, but the bigger signal may be the Ethereum Foundation's mov...
Dreaming of easy flights and hotel stays? Credit cards with bonus travel points offers can unlock big-value redemptio...